Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
5.39
-0.34 (-5.93%)
At close: Oct 23, 2026, 4:00 PM EDT
5.38
-0.01 (-0.19%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $333.34 million as of October 23, 2026. It is the 17,384th most valuable company in the world and the 3,074th biggest in the United States. Its market cap has increased by 15.56% in one year.
Market Cap
333.34M
Enterprise Value
166.91M
1-Year Change
15.56%
Global Rank
Country Rank
#3,074 United States
Category
ChartMarket Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $333.34M, a decrease of -62.88%. That is a compound annual growth rate of -30.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 333.34M | -37.93% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 385.49M |
| Prelude Therapeutics | 375.93M |
| Scribe Therapeutics | 365.38M |
| Fennec Pharmaceuticals | 364.00M |
| Orchestra BioMed Holdings | 348.91M |
| vTv Therapeutics | 345.04M |
| Nautilus Biotechnology | 344.86M |
| Relmada Therapeutics | 342.41M |